"Efficacy and safety of Valdoxan given orally once a day for 24 weeks in patients with Major Depressive Disorder." Open, national, multicentric clinical trial for the evaluation of the antidepressant efficacy and tolerability of Valdoxan and its additional clinical benefits for depressed patients.

Trial Profile

"Efficacy and safety of Valdoxan given orally once a day for 24 weeks in patients with Major Depressive Disorder." Open, national, multicentric clinical trial for the evaluation of the antidepressant efficacy and tolerability of Valdoxan and its additional clinical benefits for depressed patients.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2014

At a glance

  • Drugs Agomelatine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Servier
  • Most Recent Events

    • 06 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top